Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance.
- NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_assertion description "[The trifunctional carbamoylphosphate synthetase/aspartate transcarbamyltransferase/dihydroorotase (CAD) gene is hormone responsive in MCF-7 and ZR-75 breast cancer cells, and this response is inhibited by the aryl hydrocarbon receptor (AhR) agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance.
- NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_assertion evidence source_evidence_literature NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance.
- NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_assertion SIO_000772 16675542 NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance.
- NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_assertion wasDerivedFrom befree-20150227 NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance.
- NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_assertion wasGeneratedBy ECO_0000203 NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP278534.RA9T0LgncBOam3_GmZBBiD3dbR0KinF6ASCe2Ecn2iAwE130_provenance.